Ascendis Pharma A/S (ASND) Profit Margins
Over the twelve months to 2026-06-30, Ascendis Pharma A/S (ASND) had gross margin 91.3%, operating margin 25.4%, net margin 70.8%, free cash flow margin 32.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ASNDAscendis Pharma A/SFollow ASND — free
—
Price chart with a free account
- Market cap
- 15.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | 54.7% | 76.3% | 83.4% | 87.8% | 86.8% | 91.3% | |
| Operating margin | -7290.3% | -1462.6% | -1695.1% | -4755.1% | -5808.6% | -1097.9% | -170.8% | -76.7% | -18.9% | 25.4% | |
| Net margin | -8097.8% | -1229.5% | -1630.0% | -6025.5% | -4931.6% | -1139.6% | -180.5% | -104.0% | -31.7% | 70.8% | |
| FCF margin | -6277.1% | -1336.8% | -1354.0% | -4191.1% | -5674.4% | -997.0% | -176.1% | -84.6% | 6.3% | 32.0% |
USD millions · SEC XBRL
Ascendis Pharma A/S — questions
- What is Ascendis Pharma A/S's gross margin?
- 91.3% over the twelve months to 2026-06-30.
- What is Ascendis Pharma A/S's operating margin?
- 25.4% over the twelve months to 2026-06-30.
- What is Ascendis Pharma A/S's net profit margin?
- 70.8% over the twelve months to 2026-06-30.
Every figure on this page comes from Ascendis Pharma A/S's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.